The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Cortisol and Alzheimer's disease, I: Basal studies
Abstract
Patients with Alzheimer's disease and nondemented elderly control subjects participated in studies of cortisol secretion during sleep and at 9:00 a.m. and were given dexamethasone suppression tests (DSTs) and lumbar punctures. Nocturnal and 9:00 a.m. cortisol concentrations were significantly higher in the demented patients. CSF MHPG negatively correlated with mean nocturnal cortisol. The most severely demented patients had the highest 9:00 a.m. and mean nocturnal cortisol concentrations. DST results did not distinguish samples with substantially different nocturnal cortisol concentrations. These results suggest that measurements of basal plasma cortisol concentrations and dexamethasone suppression provide different information but support the notion of somewhat higher than normal cortisol concentrations in Alzheimer's disease patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
Research works printed but not linked: 34
- Raskind M, Am J Psychiatry, 139, 1468
- 10.1192/bjp.143.3.277 · DOI · Paper page
- 10.1001/archpsyc.1978.01770300115013 · DOI · Paper page
- 10.1176/ajp.138.9.1218 · DOI
- 10.1146/annurev.ne.03.030180.000453 · DOI · Paper page
- 10.1111/j.1532-5415.1983.tb04877.x · DOI
- 10.1126/science.155.3768.1421 · DOI
- Ferrari E, 1977, Ann Endocrinol (Paris), 38, 203
- 10.1016/0306-4530(82)90038-5 · DOI
- 10.1111/j.1365-2044.1974.tb00615.x · doi:10.1111/j.1365-2044.1974.tb00615.x
- 10.1111/j.1399-6576.1980.tb01527.x · doi:10.1111/j.1399-6576.1980.tb01527.x
- 10.1159/000122335 · DOI
- 10.1159/000122755 · doi:10.1159/000122755
- 10.1210/jcem-49-2-227 · DOI
- 10.1001/archpsyc.1980.01780200033003 · DOI
- 10.1007/BF00433054 · doi:10.1007/bf00433054
- 10.1176/ajp.139.11.1421 · DOI · Paper page
- Kay DWK, 1977, Cognitive and Emotional Disturbances in the Elderly
- 10.1016/0306-4530(83)90046-X · doi:10.1016/0306-4530(83)90046-x
- 10.1002/bms.1200020404 · DOI
- 10.1016/S0378-4347(00)81553-4 · doi:10.1016/s0378-4347(00)81553-4
- 10.1016/0022-510X(81)90106-4 · DOI · Paper page
- 10.1016/0022-510X(81)90031-9 · DOI · Paper page
- 10.1016/S0140-6736(81)92657-X · DOI · Paper page
- 10.1097/00005072-197809000-00140 · DOI
- 10.1136/bmj.2.6150.1457 · DOI · Paper page
- Davis KL, 1982, Psychopharmacol Bull, 18, 193
- 10.1016/0197-4580(81)90060-9 · DOI
- 10.1126/science.6849119 · DOI · Paper page
- 10.1001/archpsyc.1983.01790020067006 · DOI
- 10.1192/bjp.134.2.161 · DOI · Paper page
- 10.1111/j.1600-0447.1975.tb00006.x · DOI · Paper page
- 10.1210/jcem-26-9-929 · DOI
- 10.1001/archpsyc.1984.01790140069008 · DOI · Paper page
Cited by
Cortisol levels during human aging predict hippocampal atrophy and memory deficits
Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P. V., Thakur, M., McEwen, B. S., Hauger, R. L., & Meaney, M. J. (1998) · Nature Neuroscience · doi:10.1038/271 · Cited by 1,653
Effects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial
Baker, L. D., Frank, L. L., Foster-Schubert, K., Green, P. S., Wilkinson, C. W., McTiernan, A., Plymate, S. R., Fishel, M. A., Watson, G. S., Cholerton, B. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.307 · Cited by 1,171
“Hypothalamic-pituitary-adrenal axis overactivity may ultimately compromise brain resilience to stress, increasing vulnerability to neurodegeneration.(57,66,72-74) Neurodegenerative disease has been linked to changes in growth factors such as BDNF.”
The stress system in the human brain in depression and neurodegeneration
Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984
“Although some papers reported baseline levels of cortisol to be elevated in plasma and urine of AD patients (Davis et al., 1986; Maeda et al., 1991; Umegaki et al., 2000) others failed to do so (Ferrier et al., 1988).”
BackgroundChronic stress, cognitive functioning and mental health
Marin, M.-F., Lord, C., Andrews, J., Juster, R.-P., Sindi, S., Arsenault-Lapierre, G., Fiocco, A. J., & Lupien, S. J. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.02.016 · Cited by 654
Glucocorticoids increase amyloid-β and tau pathology in a mouse model of alzheimer’s disease
Green, K. N., Billings, L. M., Roozendaal, B., McGaugh, J. L., & LaFerla, F. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2797-06.2006 · Cited by 623
Basal cortisol levels and cognitive deficits in human aging
Lupien, S., Lecours, A., Lussier, I., Schwartz, G., Nair, N., & Meaney, M. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02893.1994 · Cited by 566
“…and by other studies showing significant correlations between hippocampal atrophy and hypercortisolism (Starkman et al., 1992) or else between age and hypercortisolism in disorders affecting the hippocampus, as in Alzheimer’s disease (Davis et al., 1986; DeLeon et al., 1988; Dodt et al., 199 1).”
BackgroundThe stress system in depression and neurodegeneration: Focus on the human hypothalamus
Bao, A.-M., Meynen, G., & Swaab, D. F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.04.005 · Cited by 548
Stress, memory, and the hippocampus: can't live with it, can't live without it
Lupien, S. J., & Lepage, M. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00361-8 · Cited by 515
Glucocorticoids and the regulation of memory in health and disease
de Quervain, D. J.-F., Aerni, A., Schelling, G., & Roozendaal, B. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.03.002 · Cited by 502
Revisiting the cholinergic hypothesis in the development of Alzheimer's disease
Craig, L. A., Hong, N. S., & McDonald, R. J. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.03.001 · Cited by 486
Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia
Csernansky, J. G., Dong, H., Fagan, A. M., Wang, L., Xiong, C., Holtzman, D. M., & Morris, J. C. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.12.2164 · Cited by 426
Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease
Morton, A. J., Wood, N. I., Hastings, M. H., Hurelbrink, C., Barker, R. A., & Maywood, E. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3842-04.2005 · Cited by 403
Lupien, S. J., Juster, R.-P., Raymond, C., & Marin, M.-F. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.02.001 · Cited by 387
Increase in Urinary Cortisol Excretion and Memory Declines: MacArthur Studies of Successful Aging1
Seeman, T. E., McEwen, B. S., Singer, B. H., Albert, M. S., & Rowe, J. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4173 · Cited by 370
Aging and Hypothalamic-Pituitary-Adrenal Response to Challenge in Humans*
SEEMAN, T. E., & ROBBINS, R. J. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-2-233 · Cited by 333
Accelerated neurodegeneration through chaperone-mediated oligomerization of tau
Blair, L. J., Nordhues, B. A., Hill, S. E., Scaglione, K. M., O’Leary, J. C., Fontaine, S. N., Breydo, L., Zhang, B., Li, P., Wang, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69003 · Cited by 322
“Additionally, since the FKBP5 gene is responsive to stress hormone (54), the levels of which increase in AD (59), FKBP51 could be exploited as a novel biomarker to compliment other such molecules for evaluating AD risk.”
Hartmann, A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)80309-0 · Cited by 318
Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets
Caraci, F., Copani, A., Nicoletti, F., & Drago, F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.022 · Cited by 314
Belanoff, J. K., Gross, K., Yager, A., & Schatzberg, A. F. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00018-8 · Cited by 310
Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice
Clinton, L. K., Billings, L. M., Green, K. N., Caccamo, A., Ngo, J., Oddo, S., McGaugh, J. L., & LaFerla, F. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.013 · Cited by 299
Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates
Ferrari, E., Cravello, L., Muzzoni, B., Casarotti, D., Paltro, M., Solerte, S., Fioravanti, M., Cuzzoni, G., Pontiggia, B., & Magri, F. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440319 · Cited by 290
Associations of Salivary Cortisol With Cognitive Function in the Baltimore Memory Study
Lee, B. K., Glass, T. A., McAtee, M. J., Wand, G. S., Bandeen-Roche, K., Bolla, K. I., & Schwartz, B. S. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.810 · Cited by 272
Nyakas, C., Buwald, B., & Luiten, P. G. M. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00007-x · Cited by 255
VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease
Zhou, J. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00043-e · Cited by 243
The relationship between stress and Alzheimer's disease
Justice, N. J. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.04.002 · Cited by 237
MICHELSEN, K., PRICKAERTS, J., & STEINBUSCH, H. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00912-6 · Cited by 196
“This leads to elevated cortisol levels in AD patients (Davis et al., 1986; Masugi et al., 1989).”
BackgroundCraft, S., Dagogo-Jack, S. E., Wiethop, B. V., Murphy, C., Nevins, R. T., Fleischman, S., Rice, V., Newcomer, J. W., & Cryer, P. E. (1993) · Behavioral Neuroscience · doi:10.1037/0735-7044.107.6.926 · Cited by 191
Rothman, S. M., Herdener, N., Frankola, K. A., Mughal, M. R., & Mattson, M. P. (2013) · Brain Research · doi:10.1016/j.brainres.2013.07.010 · Cited by 172
Herbert, J., & Lucassen, P. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.12.001 · Cited by 150
Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia
Csernansky, J. G., Dong, H., Fagan, A. M., Wang, L., Xiong, C., Holtzman, D. M., & Morris, J. C. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.12.2164 · Cited by 426
Milligan Armstrong, A., Porter, T., Quek, H., White, A., Haynes, J., Jackaman, C., Villemagne, V., Munyard, K., Laws, S. M., Verdile, G., et al. (2021) · Biological Reviews · doi:10.1111/brv.12750 · Cited by 116
Urinary cortisol excretion as a predictor of incident cognitive impairment
Karlamangla, A. S., Singer, B. H., Chodosh, J., McEwen, B. S., & Seeman, T. E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.037 · Cited by 112
Woods, D. L., & Dimond, M. (2002) · Biological Research For Nursing · doi:10.1177/1099800402238331 · Cited by 105
Inhibition of microglial cell activation by cortisol
Drew, P. D., & Chavis, J. A. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00275-6 · Cited by 88
Lesuis, S. L., Weggen, S., Baches, S., Lucassen, P. J., & Krugers, H. J. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0101-2 · Cited by 85
“In addition, elevated basal levels of circulating cortisol in the early disease stages 37 – 39 , as well as the failure to suppress cortisol after the dexamethasone challenge 40 – 42 , indicates that HPA axis activity is altered in AD patients.”
BackgroundJustice, N. J., Huang, L., Tian, J.-B., Cole, A., Pruski, M., Hunt, A. J., Flores, R., Zhu, M. X., Arenkiel, B. R., & Zheng, H. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3333-14.2015 · Cited by 81
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1986-03-01
- Volume
- 143
- Issue
- 3
- Pages
- 300-305
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2162943890
- Cited by
- 246
- References
- 1
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.